The ARTNet bi-annual meeting for 2024, took place at the NIH Shady Grove Campus at Rockville. This meeting served as a convergence point for all ARTNet investigators, which featured a series of talks that highlighted the scientific accomplishments, challenges, and opportunities that have emerged in the field of acquired resistance to therapy on a network-wide scale.
The meeting featured 2 thematic panel discussions on key topics with the objective to expand beyond the network’s original focal points, encouraging new collaborative opportunities and thereby enhance its impact.
1. Race/Ethnicity/Gender-based disparities in clinical patterns or biological mechanisms of acquired resistance
2. Computational Methodologies and Challenges in Utilizing AI/ML for Acquired Resistance Research
The Keynote talk on “The Multifactorial Nature of Multidrug Resistance in Cancer” was provided by Dr. Michael Gottesman.
The Keynote is now available to view via the link below:
https://nci.rev.vbrick.com/#/webcasts/artnetbi-annualscmeeting
For further information, please see the agenda.
